{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:56:34Z","timestamp":1794473794205,"version":"4.9.1"},"publisher-location":"Cham","reference-count":195,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319042190","type":"print"},{"value":"9783319042206","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-3-319-04220-6_3","type":"book-chapter","created":{"date-parts":[[2014,4,5]],"date-time":"2014-04-05T00:28:44Z","timestamp":1396657724000},"page":"91-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bacterial Pathogens"],"prefix":"10.1007","author":[{"given":"John W.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,6]]},"reference":[{"issue":"3","key":"3_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1086\/421946","volume":"39","author":"H Wisplinghoff","year":"2004","unstructured":"Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB (2004) Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 39(3):309\u2013317","journal-title":"Clin Infect Dis"},{"key":"3_CR2","unstructured":"Lyes RD, Weinstein RA, Hota B (2008) Predictors of methicillin resistance in patients with serious Staphylococcus aureus infections. In: ICAAC\/IDSA Washington, D.C"},{"issue":"3","key":"3_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1086\/499367","volume":"42","author":"RM Klevens","year":"2006","unstructured":"Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R (2006) Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992\u20132003. Clin Infect Dis 42(3):389\u2013391","journal-title":"Clin Infect Dis"},{"issue":"15","key":"3_CR4","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","volume":"298","author":"RM Klevens","year":"2007","unstructured":"Klevens RM, Morrison MA, Nadle J et al (2007) Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 298(15):1763\u20131771","journal-title":"JAMA"},{"issue":"10","key":"3_CR5","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1086\/587673","volume":"46","author":"KS Kaye","year":"2008","unstructured":"Kaye KS, Anderson DJ, Choi Y, Link K, Thacker P, Sexton DJ (2008) The deadly toll of invasive methicillin-resistant Staphylococcus aureus infection in community hospitals. Clin Infect Dis 46(10):1568\u20131577","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3_CR6","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.meegid.2008.07.007","volume":"8","author":"RH Deurenberg","year":"2008","unstructured":"Deurenberg RH, Stobberingh EE (2008) The evolution of Staphylococcus aureus. Infect Genet Evol 8(6):747\u2013763","journal-title":"Infect Genet Evol"},{"issue":"22","key":"3_CR7","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","volume":"290","author":"TS Naimi","year":"2003","unstructured":"Naimi TS, LeDell KH, Como-Sabetti K et al (2003) Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290(22):2976\u20132984","journal-title":"JAMA"},{"issue":"9","key":"3_CR8","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1086\/377501","volume":"37","author":"GK Siberry","year":"2003","unstructured":"Siberry GK, Tekle T, Carroll K, Dick J (2003) Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis 37(9):1257\u20131260","journal-title":"Clin Infect Dis"},{"issue":"9308","key":"3_CR9","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(02)07877-7","volume":"359","author":"Y Gillet","year":"2002","unstructured":"Gillet Y, Issartel B, Vanhems P et al (2002) Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359(9308):753\u2013759","journal-title":"Lancet"},{"issue":"6","key":"3_CR10","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","volume":"42","author":"G Sakoulas","year":"2004","unstructured":"Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM (2004) Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol 42(6):2398\u20132402","journal-title":"J Clin Microbiol"},{"issue":"19","key":"3_CR11","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","volume":"166","author":"LK Hidayat","year":"2006","unstructured":"Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A (2006) High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med 166(19):2138\u20132144","journal-title":"Arch Intern Med"},{"issue":"9","key":"3_CR12","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1086\/320001","volume":"32","author":"LA Mermel","year":"2001","unstructured":"Mermel LA, Farr BM, Sherertz RJ et al (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32(9):1249\u20131272","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1001\/archinte.1983.00350010034007","volume":"143","author":"DJ Winston","year":"1983","unstructured":"Winston DJ, Dudnick DV, Chapin M, Ho WG, Gale RP, Martin WJ (1983) Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med 143(1):32\u201336","journal-title":"Arch Intern Med"},{"issue":"4","key":"3_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s15010-008-7287-9","volume":"36","author":"AS Zinkernagel","year":"2008","unstructured":"Zinkernagel AS, Zinkernagel MS, Elzi MV et al (2008) Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection 36(4):314\u2013321","journal-title":"Infection"},{"issue":"1","key":"3_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.00036-07","volume":"21","author":"KL Frank","year":"2008","unstructured":"Frank KL, Del Pozo JL, Patel R (2008) From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev 21(1):111\u2013133","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"3_CR16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1128\/CMR.3.1.46","volume":"3","author":"BE Murray","year":"1990","unstructured":"Murray BE (1990) The life and times of the Enterococcus. Clin Microbiol Rev 3(1):46\u201365","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"3_CR17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1128\/jcm.28.3.435-437.1990","volume":"28","author":"KL Ruoff","year":"1990","unstructured":"Ruoff KL, de la Maza L, Murtagh MJ, Spargo JD, Ferraro MJ (1990) Species identities of enterococci isolated from clinical specimens. J Clin Microbiol 28(3):435\u2013437","journal-title":"J Clin Microbiol"},{"issue":"1","key":"3_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1093\/jac\/22.1.35","volume":"22","author":"JM Hamilton-Miller","year":"1988","unstructured":"Hamilton-Miller JM (1988) Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and \u2018folates\u2019. J Antimicrob Chemother 22(1):35\u201339","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"3_CR19","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1086\/491711","volume":"42","author":"P Courvalin","year":"2006","unstructured":"Courvalin P (2006) Vancomycin resistance in gram-positive cocci. Clin Infect Dis 42(Suppl 1):S25\u2013S34","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJM198807213190307","volume":"319","author":"R Leclercq","year":"1988","unstructured":"Leclercq R, Derlot E, Duval J, Courvalin P (1988) Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. New England J Med 319(3):157\u2013161","journal-title":"New England J Med"},{"issue":"8575\u20136","key":"3_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0140-6736(88)91037-9","volume":"1","author":"AH Uttley","year":"1988","unstructured":"Uttley AH, Collins CH, Naidoo J, George RC (1988) Vancomycin-resistant enterococci. Lancet 1(8575\u20136):57\u201358","journal-title":"Lancet"},{"issue":"4","key":"3_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/jac\/dkh138","volume":"53","author":"SF Oprea","year":"2004","unstructured":"Oprea SF, Zaidi N, Donabedian SM, Balasubramaniam M, Hershberger E, Zervos MJ (2004) Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis. J Antimicrob Chemother 53(4):626\u2013630","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"3_CR23","doi-asserted-by":"crossref","first-page":"492","DOI":"10.5694\/j.1326-5377.2005.tb06794.x","volume":"182","author":"LJ Burrell","year":"2005","unstructured":"Burrell LJ, Grabsch EA, Padiglione AA, Grayson ML (2005) Prevalence of colonisation with vancomycin-resistant enterococci (VRE) among haemodialysis outpatients in Victoria: implications for screening. The Medical journal of Australia 182(9):492","journal-title":"The Medical journal of Australia"},{"issue":"2","key":"3_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijantimicag.2003.12.019","volume":"24","author":"JM Streit","year":"2004","unstructured":"Streit JM, Jones RN, Sader HS, Fritsche TR (2004) Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 24(2):111\u2013118","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"3_CR25","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1086\/427512","volume":"191","author":"CA DiazGranados","year":"2005","unstructured":"DiazGranados CA, Jernigan JA (2005) Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 191(4):588\u2013595","journal-title":"J Infect Dis"},{"issue":"4","key":"3_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/sj.bmt.1705912","volume":"41","author":"A Zirakzadeh","year":"2008","unstructured":"Zirakzadeh A, Gastineau DA, Mandrekar JN, Burke JP, Johnston PB, Patel R (2008) Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 41(4):385\u2013392","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"3_CR27","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.ijmm.2004.10.002","volume":"294","author":"P Courvalin","year":"2005","unstructured":"Courvalin P (2005) Genetics of glycopeptide resistance in gram-positive pathogens. Int J Med Microbiol 294(8):479\u2013486","journal-title":"Int J Med Microbiol"},{"issue":"40","key":"3_CR28","first-page":"902","volume":"51","author":"D Miller","year":"2002","unstructured":"Miller D, Urdaneta V, Weltman A (2002) Vancomycin-resistant Staphylococcus aureus\u2013Pennsylvania. Mmwr 51(40):902","journal-title":"Mmwr"},{"issue":"26","key":"3_CR29","first-page":"565","volume":"51","author":"DM Sievert","year":"2002","unstructured":"Sievert DM, Boulton ML, Stoltman G, Johnson D, Stobierski MG et al (2002) Staphylococcus aureus resistant to vancomycin\u2013United States. Mmwr 51(26):565\u2013567","journal-title":"Mmwr"},{"issue":"1","key":"3_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1128\/AAC.49.1.21-25.2005","volume":"49","author":"PE Reynolds","year":"2005","unstructured":"Reynolds PE, Courvalin P (2005) Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine. Antimicrob Agents Chemother 49(1):21\u201325","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"3_CR31","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1086\/320542","volume":"32","author":"KC Reid","year":"2001","unstructured":"Reid KC, Cockerill IF, Patel R (2001) Clinical and epidemiological features of Enterococcus casseliflavus\/flavescens and Enterococcus gallinarum bacteremia: a report of 20 cases. Clin Infect Dis 32(11):1540\u20131546","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1128\/AAC.45.1.324-326.2001","volume":"45","author":"GG Zhanel","year":"2001","unstructured":"Zhanel GG, Hoban DJ, Karlowsky JA (2001) Nitrofurantoin is active against vancomycin-resistant enterococci. Antimicrob Agents Chemother 45(1):324\u2013326","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3_CR33","first-page":"565","volume":"16","author":"D Engelhard","year":"1995","unstructured":"Engelhard D, Elishoov H, Or R et al (1995) Cytosine arabinoside as a major risk factor for Streptococcus viridans septicemia following bone marrow transplantation: a 5-year prospective study. Bone Marrow Transplant 16(4):565\u2013570","journal-title":"Bone Marrow Transplant"},{"issue":"11","key":"3_CR34","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1086\/340402","volume":"34","author":"AR Tunkel","year":"2002","unstructured":"Tunkel AR, Sepkowitz KA (2002) Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis 34(11):1524\u20131529","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3_CR35","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/clinids\/14.6.1201","volume":"14","author":"LS Elting","year":"1992","unstructured":"Elting LS, Bodey GP, Keefe BH (1992) Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis 14(6):1201\u20131207","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3_CR36","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0924-8579(99)00172-7","volume":"14","author":"JL Shenep","year":"2000","unstructured":"Shenep JL (2000) Viridans-group streptococcal infections in immunocompromised hosts. Int J Antimicrob Agents 14(2):129\u2013135","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"3_CR37","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1128\/JCM.41.7.3051-3055.2003","volume":"41","author":"HZ Lu","year":"2003","unstructured":"Lu HZ, Weng XH, Zhu B et al (2003) Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis. J Clin Microbiol 41(7):3051\u20133055","journal-title":"J Clin Microbiol"},{"issue":"5","key":"3_CR38","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/jac\/47.5.693","volume":"47","author":"HF Kennedy","year":"2001","unstructured":"Kennedy HF, Gemmell CG, Bagg J, Gibson BE, Michie JR (2001) Antimicrobial susceptibility of blood culture isolates of viridans streptococci: relationship to a change in empirical antibiotic therapy in febrile neutropenia. J Antimicrob Chemother 47(5):693\u2013696","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3_CR39","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.diagmicrobio.2006.08.001","volume":"57","author":"GJ Moet","year":"2007","unstructured":"Moet GJ, Dowzicky MJ, Jones RN (2007) Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci. Diagn Microbiol Infect Dis 57(3):333\u2013336","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"12","key":"3_CR40","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s10096-005-0037-3","volume":"24","author":"RM Prabhu","year":"2005","unstructured":"Prabhu RM, Piper KE, Litzow MR, Steckelberg JM, Patel R (2005) Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis. Eur J Clin Microbiol Infect Dis 24(12):832\u2013838","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"3_CR41","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1086\/340352","volume":"34","author":"RR Razonable","year":"2002","unstructured":"Razonable RR, Litzow MR, Khaliq Y, Piper KE, Rouse MS, Patel R (2002) Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis 34(11):1469\u20131474","journal-title":"Clin Infect Dis"},{"issue":"8535","key":"3_CR42","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/S0140-6736(87)90391-6","volume":"1","author":"C Leport","year":"1987","unstructured":"Leport C, Bure A, Leport J, Vilde JL (1987) Incidence of colonic lesions in Streptococcus bovis and enterococcal endocarditis. Lancet 1(8535):748","journal-title":"Lancet"},{"issue":"7","key":"3_CR43","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1002\/1097-0142(19910401)67:7<1928::AID-CNCR2820670718>3.0.CO;2-9","volume":"67","author":"GP Bodey","year":"1991","unstructured":"Bodey GP, Rodriguez S, Fainstein V, Elting LS (1991) Clostridial bacteremia in cancer patients. A 12-year experience. Cancer 67(7):1928\u20131942","journal-title":"Cancer"},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1477-7819-7-73","volume":"7","author":"NN Mirza","year":"2009","unstructured":"Mirza NN, McCloud JM, Cheetham MJ (2009) Clostridium septicum sepsis and colorectal cancer\u2014a reminder. World J Surg Oncol 7:73","journal-title":"World J Surg Oncol"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2334-6-9","volume":"6","author":"L Senn","year":"2006","unstructured":"Senn L, Entenza JM, Greub G et al (2006) Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatella species. BMC Infect Dis 6:9","journal-title":"BMC Infect Dis"},{"issue":"3","key":"3_CR46","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1086\/381098","volume":"38","author":"CH Liao","year":"2004","unstructured":"Liao CH, Teng LJ, Hsueh PR et al (2004) Nutritionally variant streptococcal infections at a University Hospital in Taiwan: disease emergence and high prevalence of beta-lactam and macrolide resistance. Clin Infect Dis 38(3):452\u2013455","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3_CR47","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/000313480607200702","volume":"72","author":"SC Katz","year":"2006","unstructured":"Katz SC, Pachter HL (2006) Indications for splenectomy. American Surg 72(7):565\u2013580","journal-title":"American Surg"},{"issue":"2","key":"3_CR48","first-page":"120","volume":"42","author":"SJ Russell","year":"1989","unstructured":"Russell SJ, Richards JD (1989) Medical indications for splenectomy. Br J Hosp Med 42(2):120\u2013123, 5\u20136, 7","journal-title":"Br J Hosp Med"},{"issue":"3","key":"3_CR49","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1053\/jinf.2001.0904","volume":"43","author":"N Bisharat","year":"2001","unstructured":"Bisharat N, Omari H, Lavi I, Raz R (2001) Risk of infection and death among post-splenectomy patients. J Infect 43(3):182\u2013186","journal-title":"J Infect"},{"key":"3_CR50","first-page":"285","volume":"1","author":"DB Singer","year":"1973","unstructured":"Singer DB (1973) Postsplenectomy sepsis. Perspect Pediatr Pathol 1:285\u2013311","journal-title":"Perspect Pediatr Pathol"},{"issue":"2","key":"3_CR51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0732-8893(03)00116-0","volume":"47","author":"GA Rivero","year":"2003","unstructured":"Rivero GA, Torres HA, Rolston KV, Kontoyiannis DP (2003) Listeria monocytogenes infection in patients with cancer. Diagn Microbiol Infect Dis 47(2):393\u2013398","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"11","key":"3_CR52","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/sj.bmt.1703562","volume":"29","author":"A Safdar","year":"2002","unstructured":"Safdar A, Papadopoulous EB, Armstrong D (2002) Listeriosis in recipients of allogeneic blood and marrow transplantation: thirteen\u00a0year review of disease characteristics, treatment outcomes and a new association with human cytomegalovirus infection. Bone Marrow Transplant 29(11):913\u2013916","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"3_CR53","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s100960000343","volume":"19","author":"C Girmenia","year":"2000","unstructured":"Girmenia C, Iori AP, Bernasconi S et al (2000) Listeriosis in recipients of allogeneic bone marrow transplants from unrelated donors. Eur J Clin Microbiol Infect Dis 19(9):711\u2013714","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3_CR54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jac\/41.suppl_4.13","volume":"D","author":"J Klastersky","year":"1998","unstructured":"Klastersky J (1998) Science and pragmatism in the treatment and prevention of neutropenic infection. J Antimicrob Chemother 41 Suppl D:13\u201324","journal-title":"J Antimicrob Chemother 41 Suppl"},{"issue":"Suppl 1","key":"3_CR55","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1086\/383048","volume":"39","author":"R Ramphal","year":"2004","unstructured":"Ramphal R (2004) Changes in the etiology of bacteremia in febrile neutropenic patients and the susceptibilities of the currently isolated pathogens. Clin Infect Dis 39(Suppl 1):S25\u2013S31","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"3_CR56","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.ijantimicag.2007.06.012","volume":"30","author":"J Klastersky","year":"2007","unstructured":"Klastersky J, Ameye L, Maertens J et al (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51\u2013S59","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"3_CR57","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.ijantimicag.2008.06.017","volume":"32","author":"R Feld","year":"2008","unstructured":"Feld R (2008) Bloodstream infections in cancer patients with febrile neutropenia. Int J Antimicrob Agents 32(Suppl 1):S30\u2013S33","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"3_CR58","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.amjmed.2008.03.034","volume":"121","author":"HS Cheong","year":"2008","unstructured":"Cheong HS, Kang CI, Wi YM et al (2008) Clinical significance and predictors of community-onset Pseudomonas aeruginosa bacteremia. Am J Med 121(8):709\u2013714","journal-title":"Am J Med"},{"issue":"4","key":"3_CR59","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1097\/00000441-197010000-00003","volume":"60","author":"JP Whitecar Jr","year":"1970","unstructured":"Whitecar JP Jr, Luna M, Bodey GP (1970) Pseudomonas bacteremia in patients with malignant diseases. Am J Med Sci 60(4):216\u2013223","journal-title":"Am J Med Sci"},{"issue":"4","key":"3_CR60","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/archinte.160.4.501","volume":"160","author":"I Chatzinikolaou","year":"2000","unstructured":"Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G (2000) Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: retrospective analysis of 245 episodes. Arch Intern Med 160(4):501\u2013509","journal-title":"Arch Intern Med"},{"issue":"9","key":"3_CR61","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1001\/archinte.1985.00360090089015","volume":"145","author":"GP Bodey","year":"1985","unstructured":"Bodey GP, Jadeja L, Elting L (1985) Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 145(9):1621\u20131629","journal-title":"Arch Intern Med"},{"issue":"3","key":"3_CR62","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s005200050166","volume":"6","author":"MC Escande","year":"1998","unstructured":"Escande MC, Herbrecht R (1998) Prospective study of bacteraemia in cancer patients. Results of a French multicentre study. Support Care Cancer 6(3):273\u2013280","journal-title":"Support Care Cancer"},{"issue":"11","key":"3_CR63","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/sj.bmt.1705653","volume":"39","author":"M Hakki","year":"2007","unstructured":"Hakki M, Limaye AP, Kim HW, Kirby KA, Corey L, Boeckh M (2007) Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation. Bone Marrow Transplant 39(11):687\u2013693","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"3_CR64","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00001432-200108000-00001","volume":"14","author":"GP Bodey","year":"2001","unstructured":"Bodey GP (2001) Pseudomonas aeruginosa infections in cancer patients: have they gone away? Curr Opin Infect Dis 14(4):403\u2013407","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"3_CR65","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/cncr.21115","volume":"104","author":"N Ohmagari","year":"2005","unstructured":"Ohmagari N, Hanna H, Graviss L et al (2005) Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 104(1):205\u2013212","journal-title":"Cancer"},{"issue":"10","key":"3_CR66","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/S1286-4579(00)01276-4","volume":"2","author":"KS Thomson","year":"2000","unstructured":"Thomson KS, Smith Moland E (2000) Version 2000: the new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium. Microbes Infect\/Institut Pasteur 2(10):1225\u20131235","journal-title":"Microbes Infect\/Institut Pasteur"},{"issue":"12","key":"3_CR67","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1097\/01.CCM.0000245666.28867.C6","volume":"34","author":"S Nseir","year":"2006","unstructured":"Nseir S, Di Pompeo C, Cavestri B et al (2006) Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit Care Med 34(12):2959\u20132966","journal-title":"Crit Care Med"},{"issue":"8","key":"3_CR68","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","volume":"32","author":"D Cardo","year":"2004","unstructured":"Cardo D, Horan T, Andrus M, Dembinski M, Edwards J, Peavy G et al (2004) National nosocomial infections surveillance (NNIS) system report data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32(8):470\u2013485","journal-title":"Am J Infect Control"},{"issue":"9","key":"3_CR69","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ajic.2008.03.003","volume":"36","author":"VD Rosenthal","year":"2008","unstructured":"Rosenthal VD, Maki DG, Mehta A et al (2008) International nosocomial infection control consortium report, data summary for 2002\u20132007, issued January 2008. Am J Infect Control 36(9):627\u2013637","journal-title":"Am J Infect Control"},{"issue":"4","key":"3_CR70","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.8.4.557","volume":"8","author":"DM Livermore","year":"1995","unstructured":"Livermore DM (1995) beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 8(4):557\u2013584","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"3_CR71","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","volume":"14","author":"PA Bradford","year":"2001","unstructured":"Bradford PA (2001) Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14(4):933-951, table of contents","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"3_CR72","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA (2005) Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 18(4):657\u2013686","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"3_CR73","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","volume":"70","author":"JD Pitout","year":"2010","unstructured":"Pitout JD (2010) Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70(3):313\u2013333","journal-title":"Drugs"},{"issue":"4","key":"3_CR74","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/JCM.00219-10","volume":"48","author":"KS Thomson","year":"2010","unstructured":"Thomson KS (2010) Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues. J Clin Microbiol 48(4):1019\u20131025","journal-title":"J Clin Microbiol"},{"issue":"4","key":"3_CR75","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMra041359","volume":"352","author":"GA Jacoby","year":"2005","unstructured":"Jacoby GA, Munoz-Price LS (2005) The new beta-lactamases. N Engl J Med 352(4):380\u2013391","journal-title":"N Engl J Med"},{"issue":"1","key":"3_CR76","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/jac\/dki180","volume":"56","author":"EM Graffunder","year":"2005","unstructured":"Graffunder EM, Preston KE, Evans AM, Venezia RA (2005) Risk factors associated with extended-spectrum beta-lactamase-producing organisms at a tertiary care hospital. J Antimicrob Chemother 56(1):139\u2013145","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"3_CR77","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1086\/514643","volume":"27","author":"L Piroth","year":"1998","unstructured":"Piroth L, Aube H, Doise JM, Vincent-Martin M (1998) Spread of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: are beta-lactamase inhibitors of therapeutic value? Clin Infect Dis 27(1):76\u201380","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3_CR78","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/infdis\/173.1.151","volume":"173","author":"LB Rice","year":"1996","unstructured":"Rice LB, Carias LL, Bonomo RA, Shlaes DM (1996) Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy. J Infect Dis 173(1):151\u2013158","journal-title":"J Infect Dis"},{"issue":"2 Suppl","key":"3_CR79","doi-asserted-by":"publisher","first-page":"391S","DOI":"10.1378\/chest.119.2_suppl.391S","volume":"119","author":"L Rice","year":"2001","unstructured":"Rice L (2001) Evolution and clinical importance of extended-spectrum beta-lactamases. Chest 119(2 Suppl):391S\u2013396S","journal-title":"Chest"},{"issue":"2","key":"3_CR80","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/jac\/46.2.330","volume":"46","author":"T Gottlieb","year":"2000","unstructured":"Gottlieb T, Wolfson C (2000) Comparison of the MICs of cefepime for extended-spectrum beta-lactamase-producing and non-extended-spectrum beta-lactamase-producing strains of Enterobacter cloacae. J Antimicrob Chemother 46(2):330\u2013331","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"3_CR81","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1586\/14787210.6.5.657","volume":"6","author":"JD Pitout","year":"2008","unstructured":"Pitout JD (2008) Multiresistant Enterobacteriaceae: new threat of an old problem. Expert Rev Anti-infect Ther 6(5):657\u2013669","journal-title":"Expert Rev Anti-infect Ther"},{"issue":"7","key":"3_CR82","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1046\/j.1469-0691.2000.00097.x","volume":"6","author":"D Talon","year":"2000","unstructured":"Talon D, Bailly P, Bertrand X, Thouverez M, Mulin B (2000) Clinical and molecular epidemiology of chromosome-mediated resistance to third-generation cephalosporins in Enterobacter isolates in eastern France. Clin Microbiol Infect 6(7):376\u2013384","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"3_CR83","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0732-8893(97)00064-3","volume":"28","author":"MA Pfaller","year":"1997","unstructured":"Pfaller MA, Jones RN, Marshall SA et al (1997) Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis 28(4):211\u2013219","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"3_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","volume":"46","author":"A Philippon","year":"2002","unstructured":"Philippon A, Arlet G, Jacoby GA (2002) Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother 46(1):1\u201311","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"3_CR85","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1128\/AAC.45.9.2628-2630.2001","volume":"45","author":"KS Kaye","year":"2001","unstructured":"Kaye KS, Cosgrove S, Harris A, Eliopoulos GM, Carmeli Y (2001) Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother 45(9):2628\u20132630","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3_CR86","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/archinte.162.2.185","volume":"162","author":"SE Cosgrove","year":"2002","unstructured":"Cosgrove SE, Kaye KS, Eliopoulous GM, Carmeli Y (2002) Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med 162(2):185\u2013190","journal-title":"Arch Intern Med"},{"issue":"1","key":"3_CR87","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/jac\/dkh282","volume":"54","author":"A Muller","year":"2004","unstructured":"Muller A, Lopez-Lozano JM, Bertrand X, Talon D (2004) Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae. J Antimicrob Chemother 54(1):173\u2013177","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"3_CR88","first-page":"256","volume":"58","author":"W Lledo","year":"2009","unstructured":"Lledo W, Hernandez M, Lopez E, Molinari OL, Soto RQ, Hernandez E et al (2009) Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. Mmwr 58(10):256\u2013260","journal-title":"Mmwr"},{"issue":"9","key":"3_CR89","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1128\/JCM.00979-08","volume":"46","author":"R Tibbetts","year":"2008","unstructured":"Tibbetts R, Frye JG, Marschall J, Warren D, Dunne W (2008) Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC beta-lactamase in P. mirabilis. J Clin Microbiol 46(9):3080\u20133083","journal-title":"J Clin Microbiol"},{"issue":"3","key":"3_CR90","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/jac\/dkl541","volume":"59","author":"R Zhang","year":"2007","unstructured":"Zhang R, Zhou HW, Cai JC, Chen GX (2007) Plasmid-mediated carbapenem-hydrolysing beta-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother 59(3):574\u2013576","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"3_CR91","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1128\/AAC.47.4.1297-1300.2003","volume":"47","author":"V Miriagou","year":"2003","unstructured":"Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM (2003) Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother 47(4):1297\u20131300","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3_CR92","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1128\/JCM.02038-07","volume":"46","author":"JK Rasheed","year":"2008","unstructured":"Rasheed JK, Biddle JW, Anderson KF et al (2008) Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol 46(6):2066\u20132069","journal-title":"J Clin Microbiol"},{"issue":"24","key":"3_CR93","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1001\/jama.2008.896","volume":"300","author":"MJ Schwaber","year":"2008","unstructured":"Schwaber MJ, Carmeli Y (2008) Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 300(24):2911\u20132913","journal-title":"JAMA"},{"issue":"4","key":"3_CR94","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","volume":"9","author":"P Nordmann","year":"2009","unstructured":"Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9(4):228\u2013236","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"3_CR95","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1086\/592412","volume":"29","author":"G Patel","year":"2008","unstructured":"Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP (2008) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29(12):1099\u20131106","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"3_CR96","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1128\/AAC.49.7.3018-3020.2005","volume":"49","author":"S Bratu","year":"2005","unstructured":"Bratu S, Mooty M, Nichani S et al (2005) Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 49(7):3018\u20133020","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR97","unstructured":"(2010) Detection of Enterobacteriaceae isolates carrying metallo-beta-lactamase\u2014United States. Mmwr 59(24):750"},{"issue":"Suppl 4","key":"3_CR98","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1093\/clinids\/18.Supplement_4.S265","volume":"18","author":"JG Bartlett","year":"1994","unstructured":"Bartlett JG (1994) Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 18(Suppl 4):S265\u2013S272","journal-title":"Clin Infect Dis"},{"issue":"Pt 6","key":"3_CR99","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1099\/jmm.0.47775-0","volume":"57","author":"B Dupuy","year":"2008","unstructured":"Dupuy B, Govind R, Antunes A, Matamouros S (2008) Clostridium difficile toxin synthesis is negatively regulated by TcdC. J Med Microbiol 57(Pt 6):685\u2013689","journal-title":"J Med Microbiol"},{"issue":"1","key":"3_CR100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.diagmicrobio.2009.08.015","volume":"66","author":"BP Verdoorn","year":"2010","unstructured":"Verdoorn BP, Orenstein R, Rosenblatt JE et al (2010) High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis 66(1):24\u20138","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"10","key":"3_CR101","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/ndt\/gfh428","volume":"19","author":"M Schaier","year":"2004","unstructured":"Schaier M, Wendt C, Zeier M, Ritz E (2004) Clostridium difficile diarrhoea in the immunosuppressed patient\u2013update on prevention and management. Nephrol Dial Transplant 19(10):2432\u20132436","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"3_CR102","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.bmt.1702627","volume":"26","author":"S Chakrabarti","year":"2000","unstructured":"Chakrabarti S, Lees A, Jones SG, Milligan DW (2000) Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality. Bone Marrow Transplant 26(8):871\u2013876","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"3_CR103","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/sj.bmt.1705269","volume":"37","author":"JI Arango","year":"2006","unstructured":"Arango JI, Restrepo A, Schneider DL et al (2006) Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma. Bone Marrow Transplant 37(5):517\u2013521","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"3_CR104","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.1086\/521860","volume":"46","author":"DN Gerding","year":"2008","unstructured":"Gerding DN, Muto CA, Owens RC Jr (2008) Treatment of Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S32\u2013S42","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3_CR105","doi-asserted-by":"publisher","first-page":"760","DOI":"10.4065\/77.8.760","volume":"77","author":"WJ Hogan","year":"2002","unstructured":"Hogan WJ, Letendre L, Litzow MR et al (2002) Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside. Mayo Clin Proc 77(8):760\u2013762","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"3_CR106","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1128\/CMR.19.2.259-282.2006","volume":"19","author":"BA Brown-Elliott","year":"2006","unstructured":"Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr (2006) Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 19(2):259\u2013282","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"3_CR107","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/CMR.7.3.357","volume":"7","author":"MM McNeil","year":"1994","unstructured":"McNeil MM, Brown JM (1994) The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev 7(3):357\u2013417","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"3_CR108","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1093\/infdis\/134.3.286","volume":"134","author":"BL Beaman","year":"1976","unstructured":"Beaman BL, Burnside J, Edwards B, Causey W (1976) Nocardial infections in the United States, 1972\u20131974. J Infect Dis 134(3):286\u2013289","journal-title":"J Infect Dis"},{"key":"3_CR109","doi-asserted-by":"crossref","unstructured":"Rubin R, Young LS (2002) A clinical approach to infection in the compromised host, chapter 7, Mycobacteria and nocardial disease in the compromised host, pages 257\u201361, 4th edn. Kluwer Academic, New York","DOI":"10.1007\/0-306-47527-8_7"},{"issue":"5","key":"3_CR110","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1093\/clinids\/23.5.1012","volume":"23","author":"C Choucino","year":"1996","unstructured":"Choucino C, Goodman SA, Greer JP, Stein RS, Wolff SN, Dummer JS (1996) Nocardial infections in bone marrow transplant recipients. Clin Infect Dis 23(5):1012\u20131019","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3_CR111","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1086\/513654","volume":"24","author":"JA van Burik","year":"1997","unstructured":"van Burik JA, Hackman RC, Nadeem SQ et al (1997) Nocardiosis after bone marrow transplantation: a retrospective study. Clin Infect Dis 24(6):1154\u20131160","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3_CR112","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1111\/j.1572-0241.2001.03971.x","volume":"96","author":"WA Stack","year":"2001","unstructured":"Stack WA, Richardson PD, Logan RP, Mahida YR, Hawkey CJ (2001) Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine. Am J Gastroenterol 96(7):2255\u20132256","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"3_CR113","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/MAJ.0b013e318159e0b4","volume":"336","author":"Y Tada","year":"2008","unstructured":"Tada Y, Fukuoka M, Mitamura M et al (2008) Nocardiosis in adult-onset Still\u2019s disease and vasculitis syndrome. Am J Med Sci 336(1):77\u201380","journal-title":"Am J Med Sci"},{"issue":"4","key":"3_CR114","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/clind\/16.4.505","volume":"16","author":"RC Arduino","year":"1993","unstructured":"Arduino RC, Johnson PC, Miranda AG (1993) Nocardiosis in renal transplant recipients undergoing immunosuppression with cyclosporine. Clin Infect Dis 16(4):505\u2013512","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3_CR115","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1086\/318150","volume":"31","author":"SA Roberts","year":"2000","unstructured":"Roberts SA, Franklin JC, Mijch A, Spelman D (2000) Nocardia infection in heart-lung transplant recipients at Alfred Hospital, Melbourne, Australia, 1989\u20131998. Clin Infect Dis 31(4):968\u2013972","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3_CR116","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1128\/CMR.7.2.213","volume":"7","author":"BL Beaman","year":"1994","unstructured":"Beaman BL, Beaman L (1994) Nocardia species: host-parasite relationships. Clin Microbiol Rev 7(2):213\u2013264","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"3_CR117","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/S0967-5868(02)00121-2","volume":"10","author":"W Borm","year":"2003","unstructured":"Borm W, Gleixner M (2003) Nocardia brain abscess misinterpreted as cerebral infarction. J Clin Neurosci 10(1):130\u2013132","journal-title":"J Clin Neurosci"},{"issue":"4","key":"3_CR118","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00701-004-0215-6","volume":"146","author":"A Menku","year":"2004","unstructured":"Menku A, Kurtsoy A, Tucer B, Yildiz O, Akdemir H (2004) Nocardia brain abscess mimicking brain tumour in immunocompetent patients: report of two cases and review of the literature. Acta Neurochirurgica 146(4):411\u2013414, discussion 4","journal-title":"Acta Neurochirurgica"},{"key":"3_CR119","doi-asserted-by":"crossref","unstructured":"Lerner PI (1996) Nocardiosis. Clin Infect Dis 22(6):891\u2013903, quiz 4\u20135","DOI":"10.1093\/clinids\/22.6.891"},{"issue":"4","key":"3_CR120","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00005792-199807000-00004","volume":"77","author":"DP Kontoyiannis","year":"1998","unstructured":"Kontoyiannis DP, Ruoff K, Hooper DC (1998) Nocardia bacteremia. Report of 4 cases and review of the literature. Medicine 77(4):255\u201367","journal-title":"Medicine"},{"issue":"2","key":"3_CR121","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1086\/313941","volume":"31","author":"DP Kontoyiannis","year":"2000","unstructured":"Kontoyiannis DP, Jacobson KL, Whimbey EE, Rolston KV, Raad II (2000) Central venous catheter-associated Nocardia bacteremia: an unusual manifestation of nocardiosis. Clin Infect Dis 31(2):617\u2013618","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3_CR122","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/00365540410020929a","volume":"36","author":"CH Lai","year":"2004","unstructured":"Lai CH, Chi CY, Chen HP, Lai CJ, Fung CP, Liu CY (2004) Port-A catheter-associated Nocardia bacteremia detected by gallium inflammation scan: a case report and literature review. Scand J Infect Dis 36(10):775\u2013777","journal-title":"Scand J Infect Dis"},{"issue":"Pt 4","key":"3_CR123","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1099\/jmm.0.46774-0","volume":"56","author":"J Munoz","year":"2007","unstructured":"Munoz J, Mirelis B, Aragon LM et al (2007) Clinical and microbiological features of nocardiosis 1997\u20132003. J Med Microbiol 56(Pt 4):545\u2013550","journal-title":"J Med Microbiol"},{"key":"3_CR124","unstructured":"Woods GL, Brown-Elliott BA, Desmond EP, Hall GS, Heifets L, Pfyffer GE et al (2003) Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A, vol 23. Clinical and Laboratory Standards Institute (formerly NCCLS), Wayne"},{"issue":"4","key":"3_CR125","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/00019048-199507000-00011","volume":"4","author":"MM McNeil","year":"1995","unstructured":"McNeil MM, Brown JM, Hutwagner LC, Schiff TA (1995) Evaluation of therapy for Nocardia asteroides complex infection. CDN\/NCID report. Infect Dis Clin Pract 4(4):287\u2013292","journal-title":"Infect Dis Clin Pract"},{"issue":"3","key":"3_CR126","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1128\/AAC.01102-06","volume":"51","author":"E Cercenado","year":"2007","unstructured":"Cercenado E, Marin M, Sanchez-Martinez M, Cuevas O, Martinez-Alarcon J, Bouza E (2007) In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother 51(3):1102\u20131104","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3_CR127","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jac\/45.1.31","volume":"45","author":"JA Hoogkamp-Korstanje","year":"2000","unstructured":"Hoogkamp-Korstanje JA, Roelofs-Willemse J (2000) Comparative in vitro activity of moxifloxacin against Gram-positive clinical isolates. J Antimicrob Chemother 45(1):31\u201339","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3_CR128","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1086\/345907","volume":"36","author":"EH Moylett","year":"2003","unstructured":"Moylett EH, Pacheco SE, Brown-Elliott BA et al (2003) Clinical experience with linezolid for the treatment of nocardia infection. Clin Infect Dis 36(3):313\u2013318","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3_CR129","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1128\/AAC.24.5.810","volume":"24","author":"ME Gombert","year":"1983","unstructured":"Gombert ME, Aulicino TM (1983) Synergism of imipenem and amikacin in combination with other antibiotics against Nocardia asteroides. Antimicrob Agents Chemother 24(5):810\u2013811","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"3_CR130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1128\/AAC.30.2.270","volume":"30","author":"ME Gombert","year":"1986","unstructured":"Gombert ME, Aulicino TM, duBouchet L, Silverman GE, Sheinbaum WM (1986) Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline. Antimicrob Agents Chemother 30(2):270\u2013273","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"3_CR131","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1128\/AAC.34.9.1766","volume":"34","author":"ME Gombert","year":"1990","unstructured":"Gombert ME, Berkowitz LB, Aulicino TM, duBouchet L (1990) Therapy of pulmonary nocardiosis in immunocompromised mice. Antimicrob Agents Chemother 34(9):1766\u20131768","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3_CR132","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/00005792-198211000-00002","volume":"61","author":"PK Peterson","year":"1982","unstructured":"Peterson PK, Ferguson R, Fryd DS, Balfour HH Jr, Rynasiewicz J, Simmons RL (1982) Infectious diseases in hospitalized renal transplant recipients: a prospective study of a complex and evolving problem. Medicine 61(6):360\u2013372","journal-title":"Medicine"},{"issue":"8","key":"3_CR133","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.5858\/2008-132-1333-NMI","volume":"132","author":"JA Jarzembowski","year":"2008","unstructured":"Jarzembowski JA, Young MB (2008) Nontuberculous mycobacterial infections. Arch Pathol Lab Med 132(8):1333\u20131341","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"3_CR134","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1086\/420746","volume":"38","author":"K Doucette","year":"2004","unstructured":"Doucette K, Fishman JA (2004) Nontuberculous mycobacterial infection in hematopoietic stem cell and solid organ transplant recipients. Clin Infect Dis 38(10):1428\u20131439","journal-title":"Clin Infect Dis"},{"issue":"11","key":"3_CR135","first-page":"281","volume":"57","author":"R Pratt","year":"2008","unstructured":"Pratt R, Robison V, Navin T, Menzies H (2008) Trends in tuberculosis\u2013United States, 2007. Mmwr 57(11):281\u2013285","journal-title":"Mmwr"},{"issue":"1","key":"3_CR136","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/00005382-199701000-00006","volume":"12","author":"HI Libshitz","year":"1997","unstructured":"Libshitz HI, Pannu HK, Elting LS, Cooksley CD (1997) Tuberculosis in cancer patients: an update. J Thorac Imaging 12(1):41\u201346","journal-title":"J Thorac Imaging"},{"issue":"11","key":"3_CR137","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1086\/503917","volume":"42","author":"M Kamboj","year":"2006","unstructured":"Kamboj M, Sepkowitz KA (2006) The risk of tuberculosis in patients with cancer. Clin Infect Dis 42(11):1592\u20131595","journal-title":"Clin Infect Dis"},{"key":"3_CR138","unstructured":"Silva FA, Matos JO, de QMFC, Nucci M (2005) Risk factors for and attributable mortality from tuberculosis in patients with hematologic malignances. Haematologica 90(8):1110\u20131115"},{"issue":"8","key":"3_CR139","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1469-0691.2004.00954.x","volume":"10","author":"GR De La Rosa","year":"2004","unstructured":"De La Rosa GR, Jacobson KL, Rolston KV, Raad II, Kontoyiannis DP, Safdar A (2004) Mycobacterium tuberculosis at a comprehensive cancer centre: active disease in patients with underlying malignancy during 1990-2000. Clin Microbiol Infect 10(8):749\u2013752","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"3_CR140","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1164\/ajrccm.158.4.9712072","volume":"158","author":"MS Ip","year":"1998","unstructured":"Ip MS, Yuen KY, Woo PC et al (1998) Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. Am J Respir Crit Care Med 158(4):1173\u20131177","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"3_CR141","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1532\/IJH97.A10219","volume":"79","author":"J Lee","year":"2004","unstructured":"Lee J, Lee MH, Kim WS et al (2004) Tuberculosis in hematopoietic stem cell transplant recipients in Korea. Int J Hematol 79(2):185\u2013188","journal-title":"Int J Hematol"},{"issue":"12","key":"3_CR142","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1002\/ijc.24636","volume":"125","author":"HY Liang","year":"2009","unstructured":"Liang HY, Li XL, Yu XS et al (2009) Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer 125(12):2936\u20132944","journal-title":"Int J Cancer"},{"key":"3_CR143","unstructured":"Iseman M (2000) A clinician\u2019s guide to tuberculosis, chapter 6- pulmonary tuberculosis in adults, page 129. Lippincott Williams & Wilkins"},{"issue":"1","key":"3_CR144","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/RTI.0b013e31818c6b97","volume":"24","author":"JI Jung","year":"2009","unstructured":"Jung JI, Lee DG, Kim YJ, Yoon HK, Kim CC, Park SH (2009) Pulmonary tuberculosis after hematopoietic stem cell transplantation: radiologic findings. J Thorac Imaging 24(1):10\u201316","journal-title":"J Thorac Imaging"},{"issue":"5","key":"3_CR145","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1164\/ajrccm\/148.5.1292","volume":"148","author":"BE Jones","year":"1993","unstructured":"Jones BE, Young SM, Antoniskis D, Davidson PT, Kramer F, Barnes PF (1993) Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Respir Dis 148(5):1292\u20131297","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"3_CR146","first-page":"30","volume":"15","author":"B Khan","year":"2005","unstructured":"Khan B, Ahmed P, Ullah K, Hussain CA, Hussain I, Raza S (2005) Frequency of tuberculosis in haematological malignancies and stem cell transplant recipients. J Coll Physicians Surg Pak 15(1):30\u201333","journal-title":"J Coll Physicians Surg Pak"},{"issue":"6","key":"3_CR147","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/01.md.0000189090.52626.7a","volume":"84","author":"A Polesky","year":"2005","unstructured":"Polesky A, Grove W, Bhatia G (2005) Peripheral tuberculous lymphadenitis: epidemiology, diagnosis, treatment, and outcome. Medicine 84(6):350\u2013362","journal-title":"Medicine"},{"issue":"1","key":"3_CR148","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.disamonth.2006.10.001","volume":"53","author":"AA Lazarus","year":"2007","unstructured":"Lazarus AA, Thilagar B (2007) Tuberculous lymphadenitis. Dis Mon 53(1):10\u201315","journal-title":"Dis Mon"},{"issue":"4","key":"3_CR149","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0733-8619(05)70164-X","volume":"17","author":"JC Garcia-Monco","year":"1999","unstructured":"Garcia-Monco JC (1999) Central nervous system tuberculosis. Neurol Clin 17(4):737\u2013759","journal-title":"Neurol Clin"},{"issue":"5","key":"3_CR150","doi-asserted-by":"publisher","first-page":"E49","DOI":"10.1542\/peds.102.5.e49","volume":"102","author":"A Yaramis","year":"1998","unstructured":"Yaramis A, Gurkan F, Elevli M et al (1998) Central nervous system tuberculosis in children: a review of 214 cases. Pediatrics 102(5):E49","journal-title":"Pediatrics"},{"issue":"6","key":"3_CR151","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00005792-199711000-00005","volume":"76","author":"P Lesprit","year":"1997","unstructured":"Lesprit P, Zagdanski AM, de La Blanchardiere A et al (1997) Cerebral tuberculosis in patients with the acquired immunodeficiency syndrome (AIDS). Report of 6 cases and review. Medicine 76(6):423\u2013431","journal-title":"Medicine"},{"issue":"6","key":"3_CR152","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1093\/clinids\/22.6.982","volume":"22","author":"R Verdon","year":"1996","unstructured":"Verdon R, Chevret S, Laissy JP, Wolff M (1996) Tuberculous meningitis in adults: review of 48 cases. Clin Infect Dis 22(6):982\u2013988","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3_CR153","first-page":"305","volume":"120","author":"MP Sharma","year":"2004","unstructured":"Sharma MP, Bhatia V (2004) Abdominal tuberculosis. Indian J Med Res 120(4):305\u2013315","journal-title":"Indian J Med Res"},{"issue":"7","key":"3_CR154","first-page":"575","volume":"2","author":"S Chakrabarti","year":"1998","unstructured":"Chakrabarti S, Varma S, Kochhar R, Gupta S, Gupta SK, Rajwanshi A (1998) Hepatosplenic tuberculosis: a cause of persistent fever during recovery from prolonged neutropenia. Int J Tuberc Lung Dis 2(7):575\u2013579","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"3_CR155","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/BF02981913","volume":"73","author":"DG Lee","year":"2001","unstructured":"Lee DG, Choi JH, Kim YJ et al (2001) Hepatosplenic tuberculosis mimicking disseminated candidiasis in patients with acute leukemia. Int J Hematol 73(1):119\u2013121","journal-title":"Int J Hematol"},{"issue":"24","key":"3_CR156","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.3748\/wjg.v10.i24.3647","volume":"10","author":"A Uzunkoy","year":"2004","unstructured":"Uzunkoy A, Harma M, Harma M (2004) Diagnosis of abdominal tuberculosis: experience from 11 cases and review of the literature. World J Gastroenterol 10(24):3647\u20133649","journal-title":"World J Gastroenterol"},{"issue":"12","key":"3_CR157","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1002\/cncr.21541","volume":"104","author":"GM Aisenberg","year":"2005","unstructured":"Aisenberg GM, Jacobson K, Chemaly RF, Rolston KV, Raad II, Safdar A (2005) Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001\u20132005). Cancer 104(12):2882\u20132887","journal-title":"Cancer"},{"issue":"4","key":"3_CR158","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1164\/rccm.167.4.603","volume":"167","author":"HM Blumberg","year":"2003","unstructured":"Blumberg HM, Burman WJ, Chaisson RE et al (2003) American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 167(4):603\u2013662","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"3_CR159","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","volume":"271","author":"GA Colditz","year":"1994","unstructured":"Colditz GA, Brewer TF, Berkey CS et al (1994) Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. Jama 271(9):698\u2013702","journal-title":"Jama"},{"issue":"2","key":"3_CR160","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1086\/375690","volume":"37","author":"S Abad","year":"2003","unstructured":"Abad S, Gyan E, Moachon L et al (2003) Tuberculosis due to Mycobacterium bovis after alemtuzumab administration. Clin Infect Dis 37(2):e27\u2013e28","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3_CR161","first-page":"107","volume":"119","author":"E Wolinsky","year":"1979","unstructured":"Wolinsky E (1979) Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119(1):107\u2013159","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"3_CR162","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","volume":"175","author":"DE Griffith","year":"2007","unstructured":"Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175(4):367\u2013416","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3_CR163","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1053\/jinf.2001.0950","volume":"44","author":"CF von Reyn","year":"2002","unstructured":"von Reyn CF, Arbeit RD, Horsburgh CR et al (2002) Sources of disseminated Mycobacterium avium infection in AIDS. J Infect 44(3):166\u2013170","journal-title":"J Infect"},{"issue":"3","key":"3_CR164","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/MCP.0b013e3282f9e650","volume":"14","author":"MM Johnson","year":"2008","unstructured":"Johnson MM, Waller EA, Leventhal JP (2008) Nontuberculous mycobacterial pulmonary disease. Curr Opin Pulm Med 14(3):203\u2013210","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"3_CR165","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S0272-5231(02)00019-9","volume":"23","author":"TK Marras","year":"2002","unstructured":"Marras TK, Daley CL (2002) Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 23(3):553\u2013567","journal-title":"Clin Chest Med"},{"issue":"3","key":"3_CR166","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0272-5231(02)00016-3","volume":"23","author":"DE Griffith","year":"2002","unstructured":"Griffith DE (2002) Management of disease due to Mycobacterium kansasii. Clin Chest Med 23(3):613\u2013621, 6","journal-title":"Clin Chest Med"},{"issue":"12","key":"3_CR167","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1086\/504381","volume":"42","author":"MA De Groote","year":"2006","unstructured":"De Groote MA, Huitt G (2006) Infections due to rapidly growing mycobacteria. Clin Infect Dis 42(12):1756\u20131763","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3_CR168","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1093\/infdis\/165.6.1082","volume":"165","author":"SD Nightingale","year":"1992","unstructured":"Nightingale SD, Byrd LT, Southern PM, Jockusch JD, Cal SX, Wynne BA (1992) Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients. J Infect Dis 165(6):1082\u20131085","journal-title":"J Infect Dis"},{"issue":"4","key":"3_CR169","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/00126334-200408010-00001","volume":"36","author":"TK Marras","year":"2004","unstructured":"Marras TK, Daley CL (2004) A systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in HIV infection. J Acquir Immune Defic Syndr (1999) 36(4):883\u2013889","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"6","key":"3_CR170","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1086\/313801","volume":"30","author":"KL Jacobson","year":"2000","unstructured":"Jacobson KL, Teira R, Libshitz HI et al (2000) Mycobacterium kansasii infections in patients with cancer. Clin Infect Dis 30(6):965\u2013969","journal-title":"Clin Infect Dis"},{"issue":"9","key":"3_CR171","doi-asserted-by":"publisher","first-page":"698","DOI":"10.7326\/0003-4819-129-9-199811010-00004","volume":"129","author":"KC Bloch","year":"1998","unstructured":"Bloch KC, Zwerling L, Pletcher MJ et al (1998) Incidence and clinical implications of isolation of Mycobacterium kansasii: results of a 5-year, population-based study. Ann Intern Med 129(9):698\u2013704","journal-title":"Ann Intern Med"},{"issue":"1","key":"3_CR172","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1164\/ajrccm.160.1.9808052","volume":"160","author":"EL Corbett","year":"1999","unstructured":"Corbett EL, Churchyard GJ, Hay M et al (1999) The impact of HIV infection on Mycobacterium kansasii disease in South African gold miners. Am J Respir Crit Care Med 160(1):10\u201314","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3_CR173","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1378\/chest.111.1.242","volume":"111","author":"LM Kahana","year":"1997","unstructured":"Kahana LM, Kay JM, Yakrus MA, Waserman S (1997) Mycobacterium avium complex infection in an immunocompetent young adult related to hot tub exposure. Chest 111(1):242\u2013245","journal-title":"Chest"},{"issue":"3","key":"3_CR174","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1378\/chest.111.3.813","volume":"111","author":"J Embil","year":"1997","unstructured":"Embil J, Warren P, Yakrus M et al (1997) Pulmonary illness associated with exposure to Mycobacterium-avium complex in hot tub water. Hypersensitivity pneumonitis or infection? Chest 111(3):813\u2013816","journal-title":"Chest"},{"issue":"5","key":"3_CR175","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/clinids\/13.5.815","volume":"13","author":"H Akiyama","year":"1991","unstructured":"Akiyama H, Maruyama T, Uetake T, Kawaguchi K, Sakamaki H, Onozawa Y (1991) Systemic infection due to atypical mycobacteria in patients with chronic myelogenous leukemia. Rev Infect Dis 13(5):815\u2013818","journal-title":"Rev Infect Dis"},{"issue":"5","key":"3_CR176","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1086\/514981","volume":"27","author":"O Levendoglu-Tugal","year":"1998","unstructured":"Levendoglu-Tugal O, Munoz J, Brudnicki A, Fevzi Ozkaynak M, Sandoval C, Jayabose S (1998) Infections due to nontuberculous mycobacteria in children with leukemia. Clin Infect Dis 27(5):1227\u20131230","journal-title":"Clin Infect Dis"},{"issue":"7","key":"3_CR177","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1182\/blood-2003-04-1268","volume":"102","author":"ME Horwitz","year":"2003","unstructured":"Horwitz ME, Uzel G, Linton GF et al (2003) Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency. Blood 102(7):2692\u20132694","journal-title":"Blood"},{"issue":"2","key":"3_CR178","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/infdis\/169.2.289","volume":"169","author":"DP Chin","year":"1994","unstructured":"Chin DP, Hopewell PC, Yajko DM et al (1994) Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J Infect Dis 169(2):289\u2013295","journal-title":"J Infect Dis"},{"issue":"9","key":"3_CR179","first-page":"923","volume":"114","author":"P Yagupsky","year":"1990","unstructured":"Yagupsky P, Menegus MA (1990) Cumulative positivity rates of multiple blood cultures for Mycobacterium avium-intracellulare and Cryptococcus neoformans in patients with the acquired immunodeficiency syndrome. Arch Pathol Lab Med 114(9):923\u2013925","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"3_CR180","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E et al (2009) Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 49(1):1\u201345","journal-title":"Clin Infect Dis"},{"issue":"11","key":"3_CR181","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/00006454-199911000-00006","volume":"18","author":"HC Maltezou","year":"1999","unstructured":"Maltezou HC, Spyridis P, Kafetzis DA (1999) Nontuberculous mycobacterial lymphadenitis in children. Pediatr Infect Dis J 18(11):968\u2013970","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"3_CR182","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/clinids\/20.4.954","volume":"20","author":"E Wolinsky","year":"1995","unstructured":"Wolinsky E (1995) Mycobacterial lymphadenitis in children: a prospective study of 105 nontuberculous cases with long-term follow-up. Clin Infect Dis 20(4):954\u2013963","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3_CR183","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1093\/clind\/16.4.463","volume":"16","author":"CW Ingram","year":"1993","unstructured":"Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR (1993) Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 16(4):463\u2013471","journal-title":"Clin Infect Dis"},{"issue":"10","key":"3_CR184","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1001\/archderm.142.10.1287","volume":"142","author":"DZ Uslan","year":"2006","unstructured":"Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW (2006) Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol 142(10):1287\u20131292","journal-title":"Arch Dermatol"},{"issue":"2","key":"3_CR185","doi-asserted-by":"publisher","first-page":"118","DOI":"10.7326\/0003-4819-120-2-199401150-00004","volume":"120","author":"WL Straus","year":"1994","unstructured":"Straus WL, Ostroff SM, Jernigan DB et al (1994) Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 120(2):118\u2013125","journal-title":"Ann Intern Med"},{"issue":"3","key":"3_CR186","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3201\/eid0503.990307","volume":"5","author":"KM Dobos","year":"1999","unstructured":"Dobos KM, Quinn FD, Ashford DA, Horsburgh CR, King CH (1999) Emergence of a unique group of necrotizing mycobacterial diseases. Emerg Infect Dis 5(3):367\u2013378","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"3_CR187","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1378\/chest.107.4.1035","volume":"107","author":"B Dautzenberg","year":"1995","unstructured":"Dautzenberg B, Piperno D, Diot P, Truffot-Pernot C, Chauvin JP (1995) Clarithromycin in the treatment of Mycobacterium avium lung infections in patients without AIDS. Clarithromycin Study Group of France. Chest 107(4):1035\u20131040","journal-title":"Chest"},{"issue":"4","key":"3_CR188","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10156-006-0457-8","volume":"12","author":"Y Kobashi","year":"2006","unstructured":"Kobashi Y, Yoshida K, Miyashita N, Niki Y, Oka M (2006) Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates. J Infect Chemother 12(4):195\u2013202","journal-title":"J Infect Chemother"},{"issue":"12","key":"3_CR189","doi-asserted-by":"publisher","first-page":"905","DOI":"10.7326\/0003-4819-121-12-199412150-00001","volume":"121","author":"RE Chaisson","year":"1994","unstructured":"Chaisson RE, Benson CA, Dube MP et al (1994) Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team. Ann Intern Med 121(12):905\u2013911","journal-title":"Ann Intern Med"},{"issue":"5","key":"3_CR190","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1086\/317441","volume":"31","author":"GL Woods","year":"2000","unstructured":"Woods GL (2000) Susceptibility testing for mycobacteria. Clin Infect Dis 31(5):1209\u20131215","journal-title":"Clin Infect Dis"},{"issue":"6","key":"3_CR191","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/infdis\/174.6.1218","volume":"174","author":"LE Bermudez","year":"1996","unstructured":"Bermudez LE, Nash KA, Petrofsky M, Young LS, Inderlied CB (1996) Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. J Infect Dis 174(6):1218\u20131222","journal-title":"J Infect Dis"},{"issue":"9","key":"3_CR192","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.4065\/80.9.1201","volume":"80","author":"TJ Kowalski","year":"2005","unstructured":"Kowalski TJ, Berbari EF, Osmon DR (2005) Epidemiology, treatment, and prevention of community-acquired methicillin-resistant Staphylococcus aureus infections. Mayo Clinic Proc 80(9):1201\u20131207, quiz 8","journal-title":"Mayo Clinic Proc"},{"issue":"12","key":"3_CR193","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1128\/AAC.32.12.1776","volume":"32","author":"RJ Wallace Jr","year":"1988","unstructured":"Wallace RJ Jr, Steele LC, Sumter G, Smith JM (1988) Antimicrobial susceptibility patterns of Nocardia asteroides. Antimicrob Agents Chemother 32(12):1776\u20131779","journal-title":"Antimicrob Agents Chemother"},{"key":"3_CR194","doi-asserted-by":"crossref","first-page":"4961","DOI":"10.1128\/AAC.00579-09","volume":"53","author":"RH Deurenberg","year":"2009","unstructured":"Deurenberg RH, Stobberingh EE (2009) International working group on the classification of staphylococcal cassette chromosome elements. Antimicrob Agents Chemother 53:4961\u20134967","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"3_CR195","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1128\/JCM.01612-13","volume":"51","author":"B Brown-Elliott","year":"2013","unstructured":"Brown-Elliott, B et al (2013) In Vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.  J Clin Microbiol 51(10):3389\u20133394","journal-title":"J Clin Microbiol"}],"container-title":["Cancer Treatment and Research","Infectious Complications in Cancer Patients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-04220-6_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T16:40:16Z","timestamp":1676565616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-319-04220-6_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9783319042190","9783319042206"],"references-count":195,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-04220-6_3","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-319-04220-6","asserted-by":"object"}]},"ISSN":["0927-3042"],"issn-type":[{"value":"0927-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"6 April 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}